Fu, H., Zhao, J., Wang, Y., Li, Y., Li, H., Geni, R., Sun, B., Guo, C. (2026). Integrated pan cancer analysis with breast cancer validation identifies SEC13 homolog as prognostic biomarker and immunotherapy target. Scientific Reports. https://doi.org/10.1038/s41598-026-52775-2